Literatur
- 1
Attwood S E, Smyrk T C, Demeester T R et al.
Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome.
Dig Dis Sci.
1993;
38
109-116
- 2
Straumann A, Spichtin H P, Bernoulli R et al.
[Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical
clinical aspects and discrete endoscopic findings].
Schweiz Med Wochenschr.
1994;
124
1419-1429
- 3
Vitellas K M, Bennett W F, Bova J G et al.
Idiopathic eosinophilic esophagitis.
Radiology.
1993;
186
789-793
- 4
Furuta G T, Liacouras C A, Collins M H et al.
Eosinophilic esophagitis in children and adults: a systematic review and consensus
recommendations for diagnosis and treatment.
Gastroenterology.
2007;
133
1342-1363
- 5
Arora A S, Yamazaki K.
Eosinophilic esophagitis: asthma of the esophagus?.
Clin Gastroenterol Hepatol.
2004;
2
523-530
- 6
Rothenberg M E, Mishra A, Collins M H et al.
Pathogenesis and clinical features of eosinophilic esophagitis.
J Allergy Clin Immunol.
2001;
108
891-894
- 7
Kapel R C, Miller J K, Torres C et al.
Eosinophilic esophagitis: a prevalent disease in the United States that affects all
age groups.
Gastroenterology.
2008;
134
1316-1321
- 8
Croese J, Fairley S K, Masson J W et al.
Clinical and endoscopic features of eosinophilic esophagitis in adults.
Gastrointest Endosc.
2003;
58
516-522
- 9
Straumann A, Spichtin H P, Grize L et al.
Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients
for up to 11.5 years.
Gastroenterology.
2003;
125
1660-1669
- 10
Kato M, Kephart G M, Talley N J et al.
Eosinophil infiltration and degranulation in normal human tissue.
Anat Rec.
1998;
252
418-425
- 11
Gupta S K, Fitzgerald J F, Kondratyuk T et al.
Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis
of allergic eosinophilic esophagitis.
J Pediatr Gastroenterol Nutr.
2006;
42
22-26
- 12
Straumann A, Bauer M, Fischer B et al.
Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory
response.
J Allergy Clin Immunol.
2001;
108
954-961
- 13
Straumann A, Bussmann C, Zuber M et al.
Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent
and adult patients.
Clin Gastroenterol Hepatol.
2008;
6
598-600
- 14
Gonsalves N, Policarpio-Nicolas M, Zhang Q et al.
Histopathologic variability and endoscopic correlates in adults with eosinophilic
esophagitis.
Gastrointest Endosc.
2006;
64
313-319
- 15
Aceves S S, Newbury R O, Dohil R et al.
Esophageal remodeling in pediatric eosinophilic esophagitis.
J Allergy Clin Immunol.
2007;
119
206-212
- 16
Bhattacharya B, Carlsten J, Sabo E et al.
Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and
gastroesophageal reflux disease.
Hum Pathol.
2007;
38
1744-1753
- 17
Blanchard C, Wang N, Stringer K F et al.
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.
J Clin Invest.
2006;
116
536-547
- 18
Straumann A, Conus S, Degen L et al.
Budesonide is effective in adolescent and adult patients with active eosinophilic
esophagitis.
Gastroenterology.
2010;
139
1526-1537, 1537.e1
- 19
Peterson K A, Thomas K L, Hilden K et al.
Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic
esophagitis.
Dig Dis Sci.
2010;
55
1313-1319
- 20
Remedios M, Campbell C, Jones D M et al.
Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and
response to treatment with fluticasone propionate.
Gastrointest Endosc.
2006;
63
3-12
- 21
Ngo P, Furuta G T, Antonioli D A et al.
Eosinophils in the esophagus – peptic or allergic eosinophilic esophagitis? Case series
of three patients with esophageal eosinophilia.
Am J Gastroenterol.
2006;
101
1666-1670
- 22
Spergel J M, Beausoleil J L, Mascarenhas M et al.
The use of skin prick tests and patch tests to identify causative foods in eosinophilic
esophagitis.
J Allergy Clin Immunol.
2002;
109
363-368
- 23
Teitelbaum J E, Fox V L, Twarog F J et al.
Eosinophilic esophagitis in children: immunopathological analysis and response to
fluticasone propionate.
Gastroenterology.
2002;
122
1216-1225
- 24
Markowitz J E, Spergel J M, Ruchelli E et al.
Elemental diet is an effective treatment for eosinophilic esophagitis in children
and adolescents.
Am J Gastroenterol.
2003;
98
777-782
- 25
Kagalwalla A F, Sentongo T A, Ritz S et al.
Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic
esophagitis.
Clin Gastroenterol Hepatol.
2006;
4
1097-1102
- 26
Simon D, Marti H, Heer P et al.
Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway
diseases.
J Allergy Clin Immunol.
2005;
115
1090-1092
- 27
Simon D, Straumann A, Wenk A et al.
Eosinophilic esophagitis in adults – no clinical relevance of wheat and rye sensitizations.
Allergy.
2006;
61
1480-1483
- 28
Aceves S S, Bastian J F, Newbury R O et al.
Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
Am J Gastroenterol.
2007;
102
2271-2279; quiz 2280
- 29
Konikoff M R, Noel R J, Blanchard C et al.
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for
pediatric eosinophilic esophagitis.
Gastroenterology.
2006;
131
1381-1391
- 30
Schaefer E T, Fitzgerald J F, Molleston J P et al.
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic
esophagitis: a randomized trial in children.
Clin Gastroenterol Hepatol.
2008;
6
165-173
- 31
Liacouras C A, Spergel J M, Ruchelli E et al.
Eosinophilic esophagitis: a 10-year experience in 381 children.
Clin Gastroenterol Hepatol.
2005;
3
1198-1206
- 32
Stein M L, Collins M H, Villanueva J M et al.
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
J Allergy Clin Immunol.
2006;
118
1312-1319
- 33
Straumann A, Conus S, Grzonka P et al.
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis:
a randomised, placebo-controlled, double-blind trial.
Gut.
2010;
59
21-30
- 34
Straumann A, Bussmann C, Conus S et al.
Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis.
J Allergy Clin Immunol.
2008;
122
425-427
- 35
Netzer P, Gschossmann J M, Straumann A et al.
Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine
can induce and maintain long-term remission.
Eur J Gastroenterol Hepatol.
2007;
19
865-869
- 36
Attwood S E, Lewis C J, Bronder C S et al.
Eosinophilic oesophagitis: a novel treatment using Montelukast.
Gut.
2003;
52
181-185
- 37
Schoepfer A M, Gonsalves N, Bussmann C et al.
Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact
on the underlying inflammation.
Am J Gastroenterol.
2010;
105
1062-1070
- 38
Schoepfer A M, Gschossmann J, Scheurer U et al.
Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective
and safe alternative after failure of topical corticosteroids.
Endoscopy.
2008;
40
161-164
- 39
Mishra A, Wang M, Pemmaraju V R et al.
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia.
Gastroenterology.
2008;
134
204-214
- 40
Straumann A, Hruz P.
What’s new in the diagnosis and therapy of eosinophilic esophagitis?.
Curr Opin Gastroenterol.
2009;
25
366-371
Dr. med. Petr Hruz
Abteilung für Gastroenterologie und Hepatologie
Universitätsspital Basel
Petersgraben 4
CH-4031 Basel
Email: hruzp@uhbs.ch
